Beximco Pharmaceuticals Plc.

(LSE) BXP

Current Price$40.55

Market Cap$18.09B

Since IPO (2005)+228%

5 Year-100%

1 Year-99%

1 Month-99%

Beximco Pharmaceuticals Plc. Financials at a Glance

Market Cap

$18.09B

Revenue (TTM)

$46.34B

Net Income (TTM)

$6.35B

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$40.55

Volume

Open

$42.50

Price

$40.55

Volume

Open

$42.50

Previous Close

$40.55

Daily Range

$47.40 - $47.40

52-Week Range

$33.33 - $52.33

Dividend

$0.00

Beta (Volatility)

-0.03 (Low)

Price

$40.55

Volume

Open

$42.50

Previous Close

$40.55

Daily Range

$47.40 - $47.40

52-Week Range

$33.33 - $52.33

BXP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Beximco Pharmaceuticals Plc.

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,122

CEO

Iqbal Ahmed

Website

www.beximcopharma.com

Headquarters

Dhaka, 1205, BD

BXP Financials

Key Financial Metrics (TTM)

Gross Margin

44%

Operating Margin

20%

Net Income Margin

13%

Return on Equity

Return on Capital

15%

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

27.20%

Stock Overview

Market Cap

$18.09B

Shares Outstanding

446.11M

Volume

Avg. Volume

Financials (TTM)

Gross Profit

$19.63B

Operating Income

$8.67B

EBITDA

$10.64B

Operating Cash Flow

$8.36B

Capital Expenditure

$2.23B

Free Cash Flow

$6.13B

Cash & ST Invst.

$1.05B

Total Debt

$6.03B

Beximco Pharmaceuticals Plc. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2024YOY CHG

Revenue

$12.30B

+12.8%

Gross Profit

$5.57B

+13.9%

Gross Margin

45.29%

N/A

Market Cap

$18.09B

N/A

Market Cap/Employee

$3.01M

N/A

Employees

6,000

N/A

Net Income

$1.83B

+27.6%

EBITDA

$2.61B

-4.2%

Quarterly Fundamentals

Name

Q2 2024YOY CHG

Net Cash

$3.84B

+38.7%

Accounts Receivable

$4.63B

+24.8%

Inventory

$15.10B

+12.7%

Long Term Debt

$2.02B

+11.5%

Short Term Debt

$4.17B

-28.0%

Return on Assets

8.41%

N/A

Return on Invested Capital

14.51%

N/A

Free Cash Flow

$279.87M

-121.7%

Operating Cash Flow

$1.04B

-41.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ANCR.LAnimalcare Group plc

ANCR.LAnimalcare Group plc$332.50+0.15%

TSTL.LTristel PLC

TSTL.LTristel PLC$405.00+3.32%

OPT.LOptima Health plc

OPT.LOptima Health plc$188.50+1.07%

DXRX.LDiaceutics PLC

DXRX.LDiaceutics PLC$165.50+0.00%

EKF.LEKF Diagnostics Holdings plc

EKF.LEKF Diagnostics Holdings plc$26.55-0.56%

BVXP.LBioventix PLC

BVXP.LBioventix PLC$1725.00+0.00%

STX.LShield Therapeutics plc

STX.LShield Therapeutics plc$7.90-9.71%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About BXP

What is the current price of Beximco Pharmaceuticals Plc.?

Beximco Pharmaceuticals Plc. is trading at GBX 40.55 per share.

What is the 52-week range for Beximco Pharmaceuticals Plc.?

Over the past 52 weeks, Beximco Pharmaceuticals Plc. has traded between GBX 33.33 and GBX 52.33.

How much debt does Beximco Pharmaceuticals Plc. have?

As of the most recent reporting period, Beximco Pharmaceuticals Plc. reported total debt of $41.38M.

How much cash does Beximco Pharmaceuticals Plc. have on hand?

Beximco Pharmaceuticals Plc. reported $11.20M in cash and cash equivalents in its most recent financial results.

What is Beximco Pharmaceuticals Plc.’s dividend yield?

Beximco Pharmaceuticals Plc. does not currently have a dividend yield.

Beximco Pharmaceuticals Plc.

Beximco Pharmaceuticals Plc. Financials at a Glance

BXP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Beximco Pharmaceuticals Plc.

BXP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Beximco Pharmaceuticals Plc. Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BXP

What is the current price of Beximco Pharmaceuticals Plc.?

What is the 52-week range for Beximco Pharmaceuticals Plc.?

How much debt does Beximco Pharmaceuticals Plc. have?

How much cash does Beximco Pharmaceuticals Plc. have on hand?

What is Beximco Pharmaceuticals Plc.’s dividend yield?

Premium Investing Services